Literature DB >> 20159949

Modulation of silent and constitutively active nociceptin/orphanin FQ receptors by potent receptor antagonists and Na+ ions in rat sympathetic neurons.

Saifeldin Mahmoud1, Wojciech Margas, Claudio Trapella, Girolamo Caló, Victor Ruiz-Velasco.   

Abstract

The pharmacology of G protein-coupled receptors can be influenced by factors such as constitutive receptor activation and Na(+) ions. In this study, we examined the coupling of natively and heterologously expressed nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptors with voltage-dependent Ca(2+) channels after exposure to four high-affinity NOP receptor blockers [[Nphe(1)Arg(14)Lys(15)]N/OFQ-NH(2) (UFP-101), 1-[1-(cyclooctylmethyl)-1,2,3,6-tetrahydro-5-(hydroxymethyl)-4-pyridinyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (Trap-101), 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl}pyrrolidine-2-carboxamide (compound 24), and N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide hydrochloride (JTC-801)] in sympathetic neurons. The enhanced tonic inhibition of Ca(2+) currents in the absence of agonists, indicative of constitutively active NOP receptors in transfected neurons, was abolished after pretreatment with pertussis toxin. In control neurons, the four antagonists did not exert any effects when applied alone but significantly blocked the N/OFQ-mediated Ca(2+) current inhibition. Exposure of transfected neurons to UFP-101 resulted in partial agonist effects. In contrast, Trap-101, compound 24, and JTC-801 exerted inverse agonism, as measured by the loss of tonic Ca(2+) current inhibition. In experiments designed to measure the N/OFQ concentration-response relationship under varying Na(+) concentrations, a leftward shift of IC(50) values was observed after Na(+) exposure. Although similar N/OFQ efficacies were measured with all solutions, a significant decrease of Hill coefficient values was obtained with increasing Na(+) concentrations. Examination of the allosteric effects of Na(+) on heterologously overexpressed NOP receptors showed that the tonic Ca(2+) current inhibition was abolished in the presence of the monovalent cation. These results demonstrate that constitutively active NOP receptors exhibit differential blocker pharmacology and allosteric regulation by Na(+). Data are also presented demonstrating that heterologously expressed mu opioid receptors in sympathetic neurons are similarly modulated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20159949      PMCID: PMC2872970          DOI: 10.1124/mol.109.062208

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  38 in total

Review 1.  Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery.

Authors:  R A de Ligt; A P Kourounakis; A P IJzerman
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 2.  Mechanisms of inverse agonism at G-protein-coupled receptors.

Authors:  Philip G Strange
Journal:  Trends Pharmacol Sci       Date:  2002-02       Impact factor: 14.819

Review 3.  Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors.

Authors:  Roland Seifert; Katharina Wenzel-Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2002-09-06       Impact factor: 3.000

4.  Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide.

Authors:  Claudio Trapella; Carmela Fischetti; Michela Pela'; Ilaria Lazzari; Remo Guerrini; Girolamo Calo'; Anna Rizzi; Valeria Camarda; David G Lambert; John McDonald; Domenico Regoli; Severo Salvadori
Journal:  Bioorg Med Chem       Date:  2009-06-02       Impact factor: 3.641

5.  4-Aminoquinolines: novel nociceptin antagonists with analgesic activity.

Authors:  H Shinkai; T Ito; T Iida; Y Kitao; H Yamada; I Uchida
Journal:  J Med Chem       Date:  2000-11-30       Impact factor: 7.446

Review 6.  The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family.

Authors:  J S Mogil; G W Pasternak
Journal:  Pharmacol Rev       Date:  2001-09       Impact factor: 25.468

7.  Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury.

Authors:  Luca Briscini; Laura Corradini; Ennio Ongini; Rosalia Bertorelli
Journal:  Eur J Pharmacol       Date:  2002-06-28       Impact factor: 4.432

8.  Sodium ions and GTP decrease the potency of [Nphe1]N/OFQ(1-13)NH2 in blocking nociceptin/orphanin FQ receptors coupled to cyclic AMP in N1E-115 neuroblastoma cells and rat olfactory bulb.

Authors:  Maria C Olianas; Pierluigi Onali
Journal:  Life Sci       Date:  2003-05-09       Impact factor: 5.037

9.  Quantitative analysis of nociceptin in blood of patients with acute and chronic pain.

Authors:  Myoung-Hwan Ko; Yun-Hee Kim; Ran-Sook Woo; Kee-Won Kim
Journal:  Neuroreport       Date:  2002-09-16       Impact factor: 1.837

10.  Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex.

Authors:  Matteo Marti; Sara Stocchi; Francesca Paganini; Flora Mela; Carmela De Risi; Girolamo Calo'; Remo Guerrini; Timothy A Barnes; David G Lambert; Lorenzo Beani; Clementina Bianchi; Michele Morari
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

View more
  13 in total

1.  Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma.

Authors:  Shailendra R Singh; Nikol Sullo; Maria Matteis; Giuseppe Spaziano; John McDonald; Ruth Saunders; Lucy Woodman; Konrad Urbanek; Antonella De Angelis; Raffaele De Palma; Rachid Berair; Mitesh Pancholi; Vijay Mistry; Francesco Rossi; Remo Guerrini; Girolamo Calò; Bruno D'Agostino; Christopher E Brightling; David G Lambert
Journal:  Br J Pharmacol       Date:  2016-03-06       Impact factor: 8.739

2.  Allosteric sodium in class A GPCR signaling.

Authors:  Vsevolod Katritch; Gustavo Fenalti; Enrique E Abola; Bryan L Roth; Vadim Cherezov; Raymond C Stevens
Journal:  Trends Biochem Sci       Date:  2014-04-21       Impact factor: 13.807

3.  Nociceptin/orphanin FQ suppresses the excitability of neurons in the ventromedial nucleus of the hypothalamus.

Authors:  Melissa J Chee; Christopher J Price; Michael A Statnick; William F Colmers
Journal:  J Physiol       Date:  2011-04-18       Impact factor: 5.182

Review 4.  Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Authors:  John T Williams; Susan L Ingram; Graeme Henderson; Charles Chavkin; Mark von Zastrow; Stefan Schulz; Thomas Koch; Christopher J Evans; Macdonald J Christie
Journal:  Pharmacol Rev       Date:  2013-01-15       Impact factor: 25.468

Review 5.  Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.

Authors:  Lawrence Toll; Michael R Bruchas; Girolamo Calo'; Brian M Cox; Nurulain T Zaveri
Journal:  Pharmacol Rev       Date:  2016-03-08       Impact factor: 25.468

6.  A Dynamic Picture of the Early Events in Nociceptin Binding to the NOP Receptor by Metadynamics.

Authors:  Stefano Della Longa; Alessandro Arcovito
Journal:  Biophys J       Date:  2016-09-20       Impact factor: 4.033

7.  Nociceptin receptor signaling in sympathetic neurons from septic rats.

Authors:  Lacee J Laufenberg; Gregory E Weller; Charles H Lang; Victor Ruiz-Velasco
Journal:  J Surg Res       Date:  2013-04-11       Impact factor: 2.192

8.  GRK2 Dictates a Functional Switch of the Peripheral Mu-Opioid Receptor.

Authors:  Yan Zhang; Nathaniel A Jeske
Journal:  ACS Chem Neurosci       Date:  2020-11-11       Impact factor: 4.418

9.  Role of nociceptin/orphanin FQ and NOP receptors in the response to acute and repeated restraint stress in rats.

Authors:  G Delaney; K L Dawe; R Hogan; T Hunjan; J Roper; G Hazell; S J Lolait; A J Fulford
Journal:  J Neuroendocrinol       Date:  2012-12       Impact factor: 3.627

10.  Pharmacological Profile of Nociceptin/Orphanin FQ Receptors Interacting with G-Proteins and β-Arrestins 2.

Authors:  D Malfacini; C Ambrosio; M C Gro'; M Sbraccia; C Trapella; R Guerrini; M Bonora; P Pinton; T Costa; G Calo'
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.